Sino Biopharmaceutical Ltd

Overview

Sino Biopharmaceutical Ltd (Sino Biopharma), a subsidiary of CP Pharmaceutical Group, is a research driven pharmaceutical company that develops, manufactures, and markets chemical medicines, biopharmaceuticals, and Chinese medicines. It offers medicines for the treatment of hepatitis, cardio-cerebral diseases, cancer, orthopedic diseases, infectious diseases, and respiratory and digestive diseases, among others. The company offers products in various dosage forms including large volume injections, PVC-free soft bags for intravenous injections, small volume injections, powdered medicines, granulated medicines, capsules, and tablets. It works in partnership with several domestic and foreign pharmaceutical companies to advance the development of its products. Sino Biopharma is headquartered in Beijing, China.
Key Stats
Address
Unit 09, 41F, Office Tower, Convention Plaza, No. 1 Harbour Road, Wanchai, Hong Kong
Headquarters

Hong Kong

Contact

852 28029886

No of Employees

24,262

Industry

Pharmaceuticals and Healthcare

Ticker Symbol & Exchange​

1177 [HKG]

Revenue (2020)

$3,427 m

-2.3% (2020 vs 2019)
Net Income (2020)

$402 m

0.6% (2020 vs 2019)
Net Profit Margin

12 %

2.8% (2020 vs 2019)
Market Cap *

$15,081 m

EPS *

$0

  *Note: Ratios based on the share price as of 21-September-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters Sino Biopharmaceutical LtdJiangsu Hengrui Medicine Co LtdSSY Group LtdGuizhou YiBai Pharmaceutical Co Ltd
Key Information
Headquarters Hong Kong China Hong Kong China
Headquarter City - LIANYUNGANG - Guiyang
Headquarter State/Province - Jiangsu - Guizhou
No. of Employees 24,262 28,903 4,700 6,723
Entity Type Public Public Public Public

Products & Services

Sino Biopharma is a research-based company that manufactures and distributes medicines for the treatment of hepatitis, cardio-cerebral diseases, cancer, orthopedic diseases, infectious diseases, respiratory and digestive diseases. Its major products and brands include the following:

Products
  • Hepatitis Medicines:
  • Tianqingganmei (Magnesium Isoglycyrrhizinate) Injections
  • Tianqingganping (Diammonium Glycyrrhizinate) Enteric Capsules
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
Brands
  • Kaifen
  • Jiuli
  • Tianjie
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age Biography
Mao Li Chief Medical Officer Senior Management 2021 - Mr. Mao Li has been the Chief Medical Officer of the company since 2021. He is the co-founder of Johnson...
Tse Ping Senior Vice Chairman Executive Board 2020 69 Mr. Tse Ping has been the Senior Vice Chairman of the company since 2020. Prior to this role, he served...
Li Yi Director; Chief Executive Officer Executive Board 2020 59 Mr. Li Yi has been the Chief Executive Officer and Director of the company since 2020. Prior to this role,...
Theresa Tse Chairwoman Executive Board - 28 Ms. Tse Theresa has been the Chairwoman of the company. Prior to this, she worked in the investment, finance and...
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2021 New Product Approvals In January, the company has obtained drug registration certificate granted by the National Medical Products…
2021 New Product Approvals In May, the company has obtained the drug registration certificate from the National Medical Products…
2021 New Product Approvals In March, the company has obtained breakthrough therapy designation from the Food and Drug Administration…
2021 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2021 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2021 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Locations


Beijing Tide Pharmaceutical Co Ltd

Address

No.8 East Rongjing Street, Beijing Econnomic-Technological Development Area, Beijing
China

Telephone

86 10 67880648

Website

www.tidepharm.com
Jiangsu Chiatai Qingjiang Pharmaceutical Co Ltd

Address

2nd Floor, Building 9, No. 699-8 Xuanwu Avenue, Xuzhuang Software Park, Nanjing
China

Telephone

86 25 68551657

Website

www.ctqjpharm.com
Lianyungang Runzhong Pharmaceutical Co Ltd

Address

No.16 Jinqiao Rd., Lianyungang
China

Telephone

86 518 86075992

Website

rz.cttq.com
Chia Tai Tianqing Pharmaceutical Group Co Ltd

Address

No. 369 South Yuzhou Road, Haizhou District, Lianyungang
China

Telephone

86 518 86095133

Website

www.cttq.com
Shanghai Tongyong Pharmaceutical Co Ltd

Address

889# Shanghaishixing District Shen South Road, Xing
China

Telephone

86 21 64890724

Softhale NV

Address

Agoralaan, Building Abis, Diepenbeek
Belgium

Telephone

32 11 286992

Website

www.softhale.com

Deals

Number of Deals
Deal Value (US$ m)